Erector Spinae Plane Block for Analgesia During ESWL

Sohag University

Status: Enrolling

Conditions: Renal Stone

Treatments: Procedure: erector spinae plane block; Drug: Nalbuphine

Study type: Interventional

Funder types: Other

Identifiers

NCT07067996

Soh-Med--25-6-8MS

Details and patient eligibility

About

this study aims to compare between efficacy of erector spinae plane block and conventional multimodal analgesia in Extracorporeal shock wave lithotripsy

Enrollment: 60 estimated patients

Sex: All

Ages: 21 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult Patients undergoing ESWL with 2-3 cm renal stones
• patients between the ages of 21 and 60,
• both sexes,
• BMI ≥18≤30 kg/m²
• Able to give informed consent.
• Patients older than 18 years with American Society of Anesthesiologists Physical Status I or II and

Exclusion criteria

• Coagulopathy or on anticoagulants
• Infection at the ESPB injection site
• BMI ≥30 kg/m²
• Patient refusal.
• patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
• patients with a history of allergies to any study drugs

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

group A : will receive Erector Spinae Plane Block in the prone position after URS.

Active Comparator group

Description:

* Patients in the block group (Group A)will receive the ESPB in the prone position after URS. ESPB needle insertion sites will be tolerated to the location of the stone, between T7-T10 vertebra levels. With these adjustments, Following the marking of the thoracic vertebrae levels with a marker pen, * The intervention will be initiated when the transverse processes and costotransverse joints on the relevant level will be distinguished using a high frequency(10-15 MHZ) linear ultrasound probe. The needle will be inserted at a 30° angle to the skin in an in-plane and craniocaudal fashion * Proper placement will be confirmed with ultrasonography and then 20 mL of 0.25% bupivacaine solution\&5 ml lidocaine 1% will be administered through the needle for intraoperative and postoperative anaglesia.

Treatment:

Procedure: erector spinae plane block

group B : will receive nalbuphine

Active Comparator group

Description:

•(Group B) patients will receive opioids ,nalbuphine( ,1 )mg/kg over 10 minutes then repeat the dose if needed \&monitoring patients for respiratory depression

Treatment:

Drug: Nalbuphine